CannPal Cannabis News | Cannabiz

AusCann remains in holding pattern as proposed acquisition is delayed

by Steve Jones May 1, 2023April 30, 2024

An acquisition involving ASX-listed AusCann has been further delayed following changes to the proposed legalisation framework […]

AusCann offloads 52% of CannPal to founder Layton Mills in move to ‘unlock potential’ of animal business

by Steve Jones March 13, 2023April 30, 2024

Company news: Emyria; Incannex; Epsilon; AusCann

by Martin Lane March 8, 2022April 29, 2024

Company news: Montu; Live Verdure; AusCann; Cann Global; MediPharm Labs; Zelira; Canopy Growth

by Martin Lane November 4, 2021April 29, 2024

Roby Zomer

Company news: MGC Pharma; Emyria; ECS Botanics; Rua Bioscience; AusCann; Cannasouth; Cronos; Althea

by Martin Lane September 2, 2021April 26, 2024

dog

AusCann starts Australian registration of skincare product for dogs

by Martin Lane July 20, 2021April 26, 2024

Cannabis companies welcome FinClear deal

by Martin Lane July 6, 2021April 26, 2024

‘Reputation arrives on foot, and leaves on horseback’: industry urged not to rush to profitability

by Steve Jones March 18, 2021April 26, 2024

AusCann CEO Nick Woolf to step down once CannPal acquisition completes

by Martin Lane January 11, 2021April 26, 2024

dog

Auscann buys out Cannpal shares for A$17.5 million

by Emma Castle November 17, 2020April 26, 2024